PDEX Key Statistics, Chart & Performance
The current stock price of PDEX is 39.16 USD. In the past month the price increased by 16.06%. In the past year, price decreased by -27.17%.
PDEX Latest News, Press Relases and Analysis
PDEX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.11 | 217.86B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.17 | 201.96B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.41 | 146.12B | ||
| SYK | STRYKER CORP | 27.79 | 139.95B | ||
| IDXX | IDEXX LABORATORIES INC | 57.57 | 57.97B | ||
| BDX | BECTON DICKINSON AND CO | 13.42 | 55.48B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.68 | 48.73B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.21 | 38.08B | ||
| RMD | RESMED INC | 25.4 | 36.70B | ||
| DXCM | DEXCOM INC | 34.87 | 25.29B | ||
| PODD | INSULET CORP | 67.3 | 21.64B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.51 | 18.45B |
Related stock screener links
About PDEX
Company Profile
Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The company is headquartered in Irvine, California and currently employs 181 full-time employees. The firm has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. The company also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. The company has an approximately 25,000 square foot industrial building in Tustin, California (the Franklin Property).
Company Info
PRO-DEX INC
2361 McGaw Ave
Irvine CALIFORNIA 92614 US
CEO: Richard L. Van Kirk
Employees: 147
Phone: 19497693200
PRO-DEX INC / PDEX FAQ
Can you describe the business of PRO-DEX INC?
Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The company is headquartered in Irvine, California and currently employs 181 full-time employees. The firm has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. The company also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. The company has an approximately 25,000 square foot industrial building in Tustin, California (the Franklin Property).
Can you provide the latest stock price for PRO-DEX INC?
The current stock price of PDEX is 39.16 USD. The price increased by 4.26% in the last trading session.
What is the dividend status of PRO-DEX INC?
PDEX does not pay a dividend.
What is the ChartMill rating of PRO-DEX INC stock?
PDEX has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
On which exchange is PDEX stock listed?
PDEX stock is listed on the Nasdaq exchange.
Can you provide the growth outlook for PRO-DEX INC?
The Revenue of PRO-DEX INC (PDEX) is expected to grow by 4.48% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is PRO-DEX INC worth?
PRO-DEX INC (PDEX) has a market capitalization of 127.66M USD. This makes PDEX a Micro Cap stock.
PDEX Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to PDEX. When comparing the yearly performance of all stocks, PDEX is a bad performer in the overall market: 78.47% of all stocks are doing better.
PDEX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to PDEX. PDEX scores excellent on profitability, but there are some minor concerns on its financial health.
PDEX Financial Highlights
Over the last trailing twelve months PDEX reported a non-GAAP Earnings per Share(EPS) of 3.19. The EPS increased by 107.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.94% | ||
| ROA | 17.41% | ||
| ROE | 26.96% | ||
| Debt/Equity | 0.21 |
PDEX Forecast & Estimates
7 analysts have analysed PDEX and the average price target is 57.12 USD. This implies a price increase of 45.86% is expected in the next year compared to the current price of 39.16.
For the next year, analysts expect an EPS growth of -4.43% and a revenue growth 4.48% for PDEX